人工智能医疗公司Tempus AI今日盘中股价大幅上涨7.34%，引起了市场的广泛关注。
消息面上，知名投资人段永平在第四季度投资组合中新建仓了Tempus AI，持仓量达11万股，显示出对该公司在AI医疗领域前景的看好。与此同时，Tempus AI宣布推出其新型HRD-RNA癌症检测算法，该技术通过分析基因表达提供对肿瘤功能状态的实时评估，一项真实世界研究显示其能显著降低特定患者的死亡风险。
段永平的建仓操作是其对AI赛道深度布局的一部分，同时增持了英伟达等AI算力龙头，并减持了苹果以平衡资产配置。Tempus AI作为其新进持仓中专注于肿瘤精准医疗的垂直应用标的，获得了市场额外的关注度。公司新算法的发布进一步强化了其在医疗AI领域的技术领先地位，共同推动了股价的积极表现。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.